Cell therapy manufacturing workflow


Cell therapies offer an exciting new treatment paradigm for patients, but the development journey is often far more complex than traditional medicines. Beyond the initial cell type or autologous versus allogeneic decision, there is genetic modification, different delivery methods, and other factors to consider that greatly impact the manufacturing strategy. View our new infographic for an overview of a genetically modified cell therapy workflow and the key considerations at each step, ranging from plasmid production through cold chain logistics.